Our Cannabis/-Biotech company gives hope to people suffering from the neuropsychiatric disorder ‘Fragile X Syndrome (FXS)’!

As the second most common chromosomal disorder after Down syndrome, 22q is caused by a small missing piece of the 22nd chromosome. The deletion occurs near the middle of the chromosome at a location designated q11.2. It is considered a mid-line condition, with physical symptoms including characteristic palate abnormalities, heart defects, immune dysfunction, and esophageal

Nabis Holdings Enters into Manufacturing and Supply Partnership with CannaKorp for Wisp Pods Used in the Wisp Vaporizing System

Comment Cannabisradar.info: Nabis is one of few cannabis companies, who announce nearly every week some cooperations / joint venture deals! At some point, the mismatch of the low market cap relative to the expanding asset portfolio will led to a powerful price explosion of the stock price!   September 18, 2019 VANCOUVER, British Columbia, Sept.

Our Cannabis/-Biotech company gives hope to people suffering from the neuropsychiatric disorder ‚Autism Spectrum Disorder (ASD)’!

The term “autism” comes from the Greek and means “to be very self-reliant”. By Leo Kanner and Hans Asperger the term was first used for children with a profound developmental disorder. Autistic disorders can be very different. Today we speak of autism spectrum disorders (ASD). People with a disorder from the autism spectrum perceive their

Glimmer of Hope for people with ‚Epileptic Encephalopathies (DEE) ‘ from new Biotech-Pearl „GW Pharma 2.0“

Glimmer of Hope for people with ‚Epileptic Encephalopathies (DEE) ‘ from new Biotech-Pearl „GW Pharma 2.0“   Developmental & Epileptic Encephalopathies (DEE) are a heterogeneous group of rare and ultra-rare epilepsy syndromes that manifest with seizures, behavioral disturbances, or EEG abnormalities that can directly worsen cognition and behavior. These disorders are often progressive and are

Nabis Holdings Expands Arizona Footprint With Acquisition of 44,000 sq. ft. Cultivation, Fulfillment and Production Facility

Comment Cannabisradar.info: This is already the second major acquisition from Nabis in the US state of Arizona. This acquisition underpins the dynamic, focused growth strategy of the fast growing cannabis investment company with a strong focus on highly profitable assets. September 10, 2019 8:17am EDT VANCOUVER, British Columbia, Sept. 10, 2019 (GLOBE NEWSWIRE) — Nabis

Pivot Pharma enters into binding Letter of Intent to acquire a controlling interest in iAmHealth CBD UG, an online nutraceutical sales platform serving Europe

Comment Cannabisradar.info: Big news from Pivot Pharmaceuticals! On September 5, our model portfolio company announced that a binding letter of intent was signed to acquire a strategic 51% stake in iAmHealth CBD UG. IAmHealth is an online nutraceutical sales platform serving Europe (https://www.iam.health/) designed to develop and market a variety of CBD dietary supplements and